Dose-finding Study Assessing the Efficacy, Safety, and Pharmacokinetics of Daridorexant in Subjects Aged 10 to < 18 Years With Insomnia Disorder
Clinical trial NCT05423717 · COMPLETED
Trial details
- NCT number
- NCT05423717
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-06
- Primary completion
- 2026-01-12
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.